Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:China
|
| gptkbp:founded |
1958
|
| gptkbp:hasResearchCenter |
gptkb:China
|
| gptkbp:headquarters_location |
gptkb:Jinan,_Shandong,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Qilu Pharmaceutical
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:market |
gptkb:Africa
gptkb:Asia gptkb:Europe gptkb:United_States global |
| gptkbp:notableEvent |
supplied COVID-19 treatments
|
| gptkbp:notableProduct |
antibiotics
chemotherapy drugs biological drugs |
| gptkbp:numberOfEmployees |
over 14,000
|
| gptkbp:parentOrganization |
gptkb:Qilu_Pharmaceutical_Group_Co.,_Ltd.
|
| gptkbp:products |
generic drugs
active pharmaceutical ingredients |
| gptkbp:stockExchange |
not publicly listed
|
| gptkbp:subsidiary |
gptkb:Qilu_Antibiotics_Pharmaceutical_Co.,_Ltd.
|
| gptkbp:website |
http://www.qilu-pharma.com/
|
| gptkbp:bfsParent |
gptkb:T3-C
|
| gptkbp:bfsLayer |
7
|